Substance · depressant

Benzodiazepines

Benzodiazepines are a family of prescription CNS depressants. They appear on 10-panel and many expanded clinical panels, but immunoassay sensitivity varies widely by drug — some (notably clonazepam, lorazepam) are missed by older immunoassays.

Last updated:

What is Benzodiazepines?

A class of GABA-A receptor positive allosteric modulators commonly prescribed for anxiety, sleep, and seizure disorders. Panel composition matters: only newer immunoassays reliably detect lorazepam and clonazepam.

Panels that include Benzodiazepines

What drug tests detect

Drug tests for Benzodiazepines typically target the following analytes / metabolites:

  • Nordiazepam
  • Oxazepam
  • Temazepam
  • α-hydroxyalprazolam
  • 7-aminoclonazepam

Confirmation testing uses LC-MS/MS or HPLC.

Detection windows

Approximate detection windows for Benzodiazepines
Specimen Window Pattern Caveat
Urine 1–7 days occasional Highly drug-specific: lorazepam/clonazepam may be missed by older assays.
7–30 days chronic Long-acting benzodiazepines (e.g., diazepam) extend the window.
Saliva 1–5 days typical Window varies widely by drug; some are poorly detected in oral fluid.
Hair 7–90 days typical Some benzodiazepines incorporate poorly into hair.

Ranges are approximate and vary by individual physiology, hydration, dose, frequency of use, and lab cutoff. They are not predictive of whether someone will "pass" a test.

Cross-reactivity and MRO interpretation

The following can affect initial immunoassay screening and are normally resolved by mass-spectrometry confirmation and MRO review. None of these are a reason to draw conclusions from a single screening result.

  • Oxaprozin (NSAID)
  • Sertraline (rare)

Sources & references

drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.

  1. Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine) — SAMHSA